Related Experiment Videos
Brain cardioembolism. Issues in diagnosis and management
Insights
Diagnosing cardioembolism relies on indirect evidence, with echocardiography having limited use. Anticoagulant prophylaxis is recommended for specific heart conditions and after initial embolism events.
Area of Science:
- Cardiology
- Neurology
- Medical Diagnostics
Background:
- Cardioembolism diagnosis often lacks direct evidence.
- Echocardiography's utility in diagnosing cardioembolism is limited.
- Identifying patients at risk for cardioembolic events is crucial.
Purpose of the Study:
- To review the diagnostic approaches for cardioembolism.
- To evaluate the role of echocardiography in cardioembolism diagnosis.
- To assess the indications for anticoagulant prophylaxis in cardioembolic disease.
Main Methods:
- Review of diagnostic criteria for cardioembolism.
- Analysis of echocardiography's yield in various patient populations.
- Evaluation of evidence supporting anticoagulant therapy for primary and secondary prophylaxis.
Main Results:
- Diagnosis of cardioembolism is primarily based on circumstantial evidence.
- Echocardiography is most useful in young patients or those with existing heart disease.
- Anticoagulant prophylaxis is advised for acute myocardial infarction, rheumatic valvular disease, dilated cardiomyopathy, and potentially chronic nonvalvular atrial fibrillation.
- Secondary prophylaxis is recommended for similar conditions plus mitral valve prolapse.
- Acute anticoagulation is indicated post-cerebral embolism if computed tomography excludes a large infarct at 24 hours.
Conclusions:
- Cardioembolism diagnosis requires careful consideration of indirect findings.
- Echocardiography should be selectively used.
- Anticoagulant therapy is a key strategy for preventing cardioembolic events in high-risk individuals.
Abstract:
The diagnosis of cardioembolism is always based on circumstantial evidence. Echocardiography has a limited useful yield and should be reserved for young patients or older patients with clinical heart disease. Primary prophylaxis with anticoagulants appears to be reasonable for patients with acute anterior wall myocardial infarction, rheumatic valvular disease, or dilated cardiomyopathy and, possibly, for those with chronic nonvalvular atrial fibrillation. Secondary prophylaxis (after an initial embolism) is reasonable for the same conditions and, possibly, for mitral valve prolapse. Acute anticoagulation therapy is warranted when a large infarct is excluded by computed tomography 24 hours after a cerebral embolism.